Lamivudine Tablets
May 16, 2012 at 12:41 | Source: Moneycontrol.com
Sep 20, 2011 at 20:49 | Source: PTI
Dec 22, 2008 at 13:33
Sep 08, 2008 at 16:01
Dec 06, 2007 at 17:08
Photos »
/ 
Related News »
Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market for Lamivudine & Zidovudine tablets USP 150/300 mg (ANDA 202418) and is ready for launch. Lamivudine & Zidovudine ...
May 16, 2012 at 07:17 | Source: equitybulls.com
Aurobindo Pharma Limited, Hyderabad-based pharma major, has received final approval from the US FDA to manufacture and market lamivudine and zidovudine tablets USP 150/300mg (ANDA 202418) and is ready for launch. Lamivudine and zidovudine tablets USP 150 ...
May 16, 2012 at 07:17 | Source: pharmabiz.com
(RTTNews) - Pharmaceutical company Lupin Ltd. announced that its subsidiary Lupin Pharmaceuticals inc. had obtained final approval from US FDA for its Lamivudine and Zidovudine tablets, 150mg/ 300mg. The Mumbai-based company said it already commenced ...
May 16, 2012 at 05:59 | Source: RTT News
Hyderabad-based pharmaceutical company Aurobindo Pharma limited (APL) on Wednesday stated that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Lamivudine and Zidovudine tablets. According to APL ...
May 16, 2012 at 08:36 | Source: Business Standard
Lupin has received approval and subsequently launched generic Lamivudine and Zidovudine Tablets (Brand name: Combivir; market size: US$275mn; Dosage: 150mg, 300mg; Indication: Antiretroviral) in the US. The company’s launch follows expiry of Teva’s six ...
May 16, 2012 at 11:21 | Source: Stock Markets Review